(Q40702746)

22 September 2017

Advanced glycosylation end products induce NF-kappaB dependent iNOS expression in RAW 264.7 cells (English)

1 reference

22 September 2017

0 references

1 reference

Chih-Hsiung Wu

1

1 reference

22 September 2017

Chao-Ming Huang

2

1 reference

22 September 2017

Chien-Huang Lin

3

1 reference

22 September 2017

Yuan-Sun Ho

4

1 reference

22 September 2017

Chien-Ming Chen

5

1 reference

22 September 2017

Horng-Mo Lee

6

1 reference

22 September 2017

1 August 2002

1 reference

Molecular and Cellular Endocrinology

22 September 2017

1 reference

22 September 2017

194

1 reference

22 September 2017

1-2

1 reference

22 September 2017

9-17

1 reference

Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

NF-kappa B: ten years after

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Glycosylation products as toxic mediators of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Epstein-Barr virus envelope glycoprotein gp350 induces NF-kappaB activation and IL-1beta synthesis in human monocytes-macrophages involving PKC and PI3-K.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Investigations on oxidative stress and therapeutical implications in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

LPS induction of gene expression in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Effect of Advanced Glycation End Product–Modified Albumin on Tissue Factor Expression by Monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Activation of nuclear factor kappaB and induction of inducible nitric oxide synthase by Ureaplasma urealyticum in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Advanced glycosylation end products induce nitric oxide synthase expression in C6 glioma cells: involvement of a p38 MAP kinase-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

The role of oxidative stress and NF-kappaB activation in late diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Ultrastructural changes and immunohistochemical localization of nitric oxide synthase, advanced glycation end products and NF-kappa B in aorta of streptozotocin treated Mongolian gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Effect of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900212-5

7 January 2021

10.1016/S0303-7207(02)00212-5

Identifiers

DOI

1 reference

22 September 2017

1 reference